etoposide has been researched along with Cerebral Primitive Neuroectodermal Tumor in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (19.61) | 18.2507 |
| 2000's | 26 (50.98) | 29.6817 |
| 2010's | 12 (23.53) | 24.3611 |
| 2020's | 3 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Dunkel, IJ; Ellison, DW; Ermoian, R; Fouladi, M; Geyer, JR; Goldman, S; Hadley, J; Huang, J; Kilburn, L; Kocak, M; Leary, SES; MacDonald, TJ; Northcott, PA; Olson, JM; Onar-Thomas, A; Phillips, P; Smith, KS; Young Poussaint, T | 1 |
| Chowdhury, T; Duncan, C; Karaa, EK; Reddy, MA; Sagoo, MS; Scheimberg, I; Sheriff, IHN | 1 |
| Bajpai, J; Chatterjee, A; Chinnaswamy, G; Desai, S; Gulia, A; Jambhekar, N; Janu, A; Juvekar, S; Khanna, N; Kurkure, P; Laskar, S; Manjali, JJ; Muckaden, MA; Nayak, P; Prasad, M; Purandare, N; Puri, A; Rangarajan, V; Rekhi, B; Shah, S; Sinha, S; Vora, T | 1 |
| Clark, C; Gaze, MN; Mankad, K; Michalski, A; Seunarine, K; Szychot, E; Thust, S | 1 |
| Antonelli, M; Biassoni, V; Gandola, L; Giangaspero, F; Massimino, M; Modena, P; Pecori, E; Poggi, G; Schiavello, E; Spreafico, F; Vajna De Pava, M | 1 |
| Garami, M; Hauser, P; Pócza, T; Schuler, D; Vancsó, I | 1 |
| Iwafuchi, H; Iwama, J; Kiyotani, C; Matsuoka, K; Morota, N; Ogiwara, H; Terashima, K | 1 |
| Aoyama, H; Fujieda, K; Ikeda, J; Ishii, N; Iwasaki, Y; Kashiwamura, M; Sawamura, Y; Shirato, H; Taguchi, H; Yasuda, K | 1 |
| Allen, J; Chan, KW; Donahue, B; Holmes, E; Jakacki, R; Mehta, M; Miller, DC; Muraszko, K; Prados, M; Puccetti, D; Robertson, P; Rorke, LB; Sposto, R; Vezina, G | 1 |
| André, N; De Paula, AM; Gentet, JC; Padovani, L; Pasquier, E; Rome, A; Scavarda, D | 1 |
| Esparza, J; Hinojosa, J; Iglesias, S; Muñoz, MJ; Otero-Rodríguez, A; Ricoy, JR; Rodríguez-Gil, Y | 1 |
| Horiuchi, K; Kondo, Y; Mizutani, S; Ohgaki, K; Sato, M | 1 |
| Andreoiu, M; Beck, SDW; Brames, MJ; Cheng, L; Ehrlich, Y; Einhorn, LH; Foster, RS; Ulbright, TM | 1 |
| Bakhshi, S; Chawla, B; Kashyap, S; Meel, R; Mohanti, BK | 1 |
| Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Yamashita, Y | 1 |
| Anson, J; Gollard, RP; Khoury, J; Mason, J; Rosen, L | 1 |
| Patel, S; Rao, P; Richey, SL; Tannir, NM; Wood, CG | 1 |
| Gandhi, V; Nagral, A; Nagral, S; Sable, S | 1 |
| Benesch, M; Deinlein, F; Faldum, A; Friedrich, C; Gerber, NU; Kortmann, RD; Kuehl, J; Kwiecien, R; Ottensmeier, H; Pietsch, T; Rutkowski, S; von Bueren, AO; von Hoff, K; Warmuth-Metz, M | 1 |
| Adams, R; Albritton, K; Coffin, C; Goldsby, R; Pulsipher, M; Wagner, L | 1 |
| Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ | 2 |
| Debelenko, L; Granowetter, L; Hensle, TW; Lam, JS; Tennenbaum, SY | 1 |
| McLean, TW | 1 |
| Aoyagi, N; Boshi, H; Kounami, S; Nakayama, K; Sakiyama, M; Takeuchi, T; Yoshikawa, N; Yoshiyama, M | 1 |
| Cmelak, A; Jennings, MT; Johnson, MD; Moots, PL; Pais, R; Shyr, Y | 1 |
| Casanova, M; Cefalo, G; Collini, P; Ferrari, A; Fossati-Bellani, F; Gandola, L; Giangaspero, F; Luksch, R; Massimino, M; Meazza, C; Pignoli, E; Podda, M; Poggi, G; Polastri, D; Ravagnani, F; Simonetti, F; Spreafico, F; Terenziani, M | 1 |
| Chen, SH; Hung, CS; Jung, SM; Lo, FS; Lui, TN; Wang, HS | 1 |
| Kamani, N; Lafond, D; Loechelt, B; MacDonald, TJ; Packer, RJ; Perez-Albuerne, E; Rood, B; Thorarinsdottir, HK | 1 |
| Boldrini, R; Cozza, R; De Ioris, M; De Sio, L; Dominici, C; Donfrancesco, A; Ilari, I; Inserra, A; Jenkner, A; Milano, GM | 1 |
| Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ | 1 |
| Allen, J; Atlas, MP; Dunkel, IJ; Fangusaro, JR; Finlay, JL; Gardner, S; Gonzalez-Gomez, I; Jubran, RF; Miller, D; Rosenblum, M | 1 |
| Ahn, SD; Cho, EJ; Choi, ES; Ghim, TT; Koo, HH; Lim, DH; Ra, YS; Shin, HJ; Sung, KW; Yoo, KH | 1 |
| Knight, PJ; Schutte, WP | 1 |
| Burke, MJ; Duerst, RE; Jacobsohn, DA; Kletzel, M; Walterhouse, DO | 1 |
| Cinaz, P; Yeşilkaya, E | 1 |
| Abromowitch, M; Allen, J; Asgharzadeh, S; Comito, M; Diez, B; Dubowy, R; Dunkel, I; Fangusaro, J; Finlay, J; Gardner, S; Halpern, S; Hukin, J; Ji, L; Kellie, S; Miller, DC; Olshefski, R; Rosenblum, M; Saly, M; Sposto, R; Zacharoulis, S | 1 |
| Choi, LM; Kamani, N; La Fond, D; Macdonald, TJ; Packer, RJ; Rood, B; Santi, MR | 1 |
| Sterling-Levis, K; White, L | 1 |
| Aledo, A; Boland, P; Casper, ES; Gerald, WL; Healey, JH; Heller, G; Kushner, BH; La Quaglia, MP; Meyers, PA; Wollner, N | 1 |
| Barrett, A; Gaze, MN; Rampling, RP; Simpson, E; Smith, DB | 1 |
| Brummett, RE; Dahlborg, SA; Dana, BW; Henner, WD; Neuwelt, EA; Roman-Goldstein, S; Tableman, M; Williams, PC | 1 |
| Roychoudhury, A; Sarkar, C; Shah, N | 1 |
| Ardouin, P; Bénard, J; Bissery, MC; Boland, I; Bressac-de-Paillerets, B; Gouyette, A; Gyergyay, F; Morizet, J; Terrier-Lacombe, MJ; Vassal, G; Vénuat, AM | 1 |
| Abe, H; Ikeda, J; Ishii, N; Kato, T; Sawamura, Y; Shirato, H; Tada, M | 1 |
| Fryer, CJ; Lawlor, ER; Murphy, JI; Sorensen, PH | 1 |
| Fisher, C; Harmer, CL; Judson, IR; Thomas, JM; Verrill, MW; Wiltshaw, E | 1 |
| Alla, P; Carloz, E; de Jauréguiberry, JP; Gisserot, O; Jaubert, D; Valance, J | 1 |
| Cain, AM; Greenwald, C; Marina, NM; Meyer, WH; Pappo, AS; Parham, DM; Poquette, CA; Pratt, CB; Rao, BN | 1 |
| Kushner, BH; Meyers, PA | 1 |
| Ashley, DM; Chow, CW; Gray, AZ; Hawkins, CJ; Riffkin, CD | 1 |
3 review(s) available for etoposide and Cerebral Primitive Neuroectodermal Tumor
| Article | Year |
|---|---|
Purely intramedullary spinal cord primitive neuroectodermal tumor: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Humans; Infant; Magnetic Resonance Imaging; Male; Methotrexate; Neuroectodermal Tumors, Primitive; Paraparesis; Prognosis; Spinal Cord Neoplasms; Thoracic Vertebrae | 2009 |
Medulloblastomas and central nervous system primitive neuroectodermal tumors.
Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Cerebellar Neoplasms; Cisplatin; Cyclophosphamide; Emergency Medical Services; Etoposide; Humans; Life Style; Lomustine; Medulloblastoma; Neuroectodermal Tumors, Primitive; Neurosurgical Procedures; Radiotherapy; Self-Help Groups; Social Support; Spinal Puncture; Vincristine | 2003 |
How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Brain Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Melphalan; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Thiotepa; Vincristine; Whole-Body Irradiation | 2001 |
16 trial(s) available for etoposide and Cerebral Primitive Neuroectodermal Tumor
| Article | Year |
|---|---|
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Isotretinoin; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Prospective Studies; Vincristine; Vorinostat | 2022 |
Radiation Therapy Dose Escalation in Unresectable Ewing Sarcoma: Final Results of a Phase 3 Randomized Controlled Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Young Adult | 2022 |
Evolving of therapeutic strategies for CNS-PNET.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Neuroectodermal Tumors, Primitive; Thiotepa; Vincristine | 2013 |
Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Analysis | 2008 |
A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Vincristine; Young Adult | 2009 |
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine | 2003 |
Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Glioma; Humans; Male; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive; Pilot Projects; Statistics, Nonparametric; Survival Rate; Vincristine | 2004 |
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experie
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Rate; Vincristine | 2006 |
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Neural Tube Defects; Neuroectodermal Tumors, Primitive; Proportional Hazards Models; Risk; Sarcoma, Ewing; Vincristine | 2007 |
Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Damage, Chronic; Brain Stem; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Humans; Infant; Infratentorial Neoplasms; Leucovorin; Mesna; Methotrexate; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Remission Induction; Thiotepa; Transplantation, Autologous; Vincristine | 2008 |
High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Contraindications; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Infections; Kaplan-Meier Estimate; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Sepsis; Supratentorial Neoplasms; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and I
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Male; Mesna; Methotrexate; Neuroectodermal Tumors, Primitive; Supratentorial Neoplasms; Survival Rate; Vincristine | 2008 |
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Remission Induction; Risk Factors; Sarcoma, Ewing; Survival Rate; Vincristine | 1995 |
Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Child; Etoposide; Female; Germinoma; Glioblastoma; Humans; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Tomography, X-Ray Computed | 1995 |
Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma, Ewing; Soft Tissue Neoplasms; Survival Rate | 1999 |
32 other study(ies) available for etoposide and Cerebral Primitive Neuroectodermal Tumor
| Article | Year |
|---|---|
Systemic adjuvant chemotherapy for advanced malignant ocular medulloepithelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Etoposide; Eye Enucleation; Humans; Male; Neuroectodermal Tumors, Primitive; Retrospective Studies; Vincristine | 2023 |
Impact of induction chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa on brain volume loss and functional status of children with primitive neuroectodermal tumour.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Child, Preschool; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Male; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Prognosis; Retrospective Studies; Survival Rate; Thiotepa; Tumor Burden | 2017 |
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow; Brain Neoplasms; Brain Stem Neoplasms; Carcinoma; Celecoxib; Cerebellar Neoplasms; Child; Child, Preschool; Choroid Plexus Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Hungary; Ischemic Attack, Transient; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Optic Nerve Glioma; Pyrazoles; Quality of Life; Retrospective Studies; Sulfonamides; Thalidomide; Treatment Outcome | 2013 |
Neoadjuvant chemotherapy for brain tumors in infants and young children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Carcinoma, Embryonal; Child; Child, Preschool; Choroid Plexus Neoplasms; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Ependymoma; Etoposide; Female; Glioblastoma; Humans; Infant; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive; Retrospective Studies; Rhabdoid Tumor; Second-Look Surgery; Treatment Outcome; Vincristine | 2015 |
Metronomic chemotherapy-induced bilateral subdural hematoma in a child with meningeal carcinomatosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Celecoxib; Child; Cyclooxygenase 2 Inhibitors; Cyclophosphamide; Etoposide; Hematoma, Subdural, Intracranial; Humans; Male; Meningeal Carcinomatosis; Neuroectodermal Tumors, Primitive; Pyrazoles; Sulfonamides | 2009 |
Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Doxorubicin; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Liver Neoplasms; Male; Nephrectomy; Neuroectodermal Tumors, Primitive; Positron-Emission Tomography; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Rate; Teratoma; Treatment Outcome; Vincristine; Young Adult | 2010 |
Ocular medulloepithelioma chemosensitivity.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Ciliary Body; Etoposide; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Uveal Neoplasms; Vincristine | 2010 |
[The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Ependymoma; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Retrospective Studies | 2010 |
Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Female; Humans; Methylprednisolone Hemisuccinate; Neuroectodermal Tumors, Primitive; Neuroprotective Agents; Radiotherapy; Spinal Neoplasms; Temozolomide; Thiotepa; Thoracic Vertebrae; Vincristine; Young Adult | 2011 |
Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Humans; Ifosfamide; Induction Chemotherapy; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Maintenance Chemotherapy; Male; Middle Aged; Neuroectodermal Tumors, Primitive; Radiography; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2012 |
Management of a large retroperitoneal primitive neuroectodermal tumour: 'a multimodal approach'.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Vincristine | 2012 |
Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child, Preschool; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Methotrexate; Neoplasm Grading; Neoplasm, Residual; Neuroectodermal Tumors, Primitive; Neuropsychological Tests; Pineal Gland; Pinealoma; Prognosis; Prospective Studies; Quality of Life; Survival Rate; Vincristine | 2013 |
Unexpected pleural effusions in 3 pediatric patients treated with STI-571.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow Transplantation; Camptothecin; Child; Combined Modality Therapy; Edema; Enzyme Inhibitors; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Irinotecan; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Lung Neoplasms; Male; Neoplasm Proteins; Neuroectodermal Tumors, Primitive; Piperazines; Pleural Effusion; Proto-Oncogene Proteins c-kit; Pyrimidines; Remission Induction; Sarcoma, Ewing; Testis; Topotecan | 2002 |
Organ-confined primitive neuroectodermal tumor arising from the kidney.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Nephrectomy; Neuroectodermal Tumors, Primitive; Remission Induction; Vincristine; Weight Loss | 2003 |
Fatal pulmonary thromboembolism after a second course of high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Fatal Outcome; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Pulmonary Embolism; Transplantation, Autologous; Vincristine | 2003 |
Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chi-Square Distribution; Child; Child, Preschool; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lomustine; Male; Methotrexate; Neuroectodermal Tumors, Primitive; Prospective Studies; Stem Cell Transplantation; Supratentorial Neoplasms; Survival Analysis; Thiotepa; Treatment Outcome; Vincristine | 2006 |
Primitive neuroectodermal tumor of the brain in a girl with Turner syndrome diagnosed after 4 years of growth hormone therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Growth Disorders; Human Growth Hormone; Humans; Magnetic Resonance Imaging; Neuroectodermal Tumors, Primitive; Radiotherapy, Adjuvant; Recombinant Proteins; Turner Syndrome | 2006 |
Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cognition Disorders; Cranial Irradiation; Cyclophosphamide; Developmental Disabilities; Disease-Free Survival; Ependymoma; Etoposide; Follow-Up Studies; Ganglioglioma; Glioma; Humans; Infant; Medulloblastoma; Mitotic Index; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Peripheral Blood Stem Cell Transplantation; Quadriplegia; Retrospective Studies; Sensation Disorders; Spinal Cord Neoplasms; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Precocious puberty because of a pancreatic neuroectodermal tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Neuroectodermal Tumors, Primitive; Pancreatic Neoplasms; Puberty, Precocious; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive; Pelvic Bones; Peripheral Blood Stem Cell Transplantation; Remission Induction; Risk; Sarcoma, Ewing; Scapula; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Neuroendocrine tumor of the pancreas resulting in precocious puberty.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Neuroectodermal Tumors, Primitive; Pancreatic Neoplasms; Puberty, Precocious; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2007 |
Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Feasibility Studies; Ganglioglioma; Humans; Infant; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Quality of Life; Retrospective Studies; Thiotepa; Treatment Outcome; Vincristine | 2008 |
Multiagent chemotherapy studied in a xenograft model of medulloblastoma/primitive neuroectodermal tumour: analysis of the VETOPEC regimen.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child, Preschool; Cyclophosphamide; Etoposide; Humans; Medulloblastoma; Mice; Mice, Nude; Neuroectodermal Tumors, Primitive; Time Factors; Vincristine; Xenograft Model Antitumor Assays | 2008 |
Combination chemotherapy for primitive neuroectodermal and other malignant brain tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Male; Neuroectodermal Tumors, Primitive; Vincristine | 1994 |
Primitive neuroectodermal tumor of maxilla in an adult.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Male; Maxillary Neoplasms; Neuroectodermal Tumors, Primitive; Radiotherapy, Adjuvant; Vincristine | 1995 |
Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Female; Humans; Irinotecan; Mice; Mice, Nude; Neuroblastoma; Neuroectodermal Tumors, Primitive; Neuroectodermal Tumors, Primitive, Peripheral; Paclitaxel; Thiotepa; Topoisomerase I Inhibitors; Transplantation, Heterologous | 1996 |
Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Irradiation; Disease-Free Survival; Etoposide; Female; Hearing Loss; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Pilot Projects; Radiotherapy, Adjuvant; Remission Induction; Skull Base Neoplasms | 1996 |
Metastatic primitive neuroectodermal tumour of the ovary: successful treatment with mega-dose chemotherapy followed by peripheral blood progenitor cell rescue.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Neuroectodermal Tumors, Primitive; Ovarian Neoplasms | 1997 |
The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Mesna; Middle Aged; Neuroectodermal Tumors, Primitive; Neutropenia; Sarcoma, Ewing; Vincristine | 1997 |
[Meningoradiculitis revealing an occult medulloblastoma-PNET in an adult].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Etoposide; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Meningitis; Methotrexate; Middle Aged; Neuroectodermal Tumors, Primitive; Oculomotor Nerve; Polyradiculopathy | 1998 |
Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
Topics: Adolescent; Animals; Antineoplastic Agents; Apoptosis; Astrocytoma; Brain Neoplasms; Cell Survival; Child; Child, Preschool; Colorimetry; Culture Media, Conditioned; DNA, Complementary; Drug Resistance, Neoplasm; Etoposide; Fas Ligand Protein; fas Receptor; Female; Ganglioglioma; Germinoma; Glioblastoma; Humans; Infant; Jurkat Cells; Male; Medulloblastoma; Membrane Glycoproteins; Mice; Neoplasm Proteins; Neuroblastoma; Neuroectodermal Tumors, Primitive; Pineal Gland; Pinealoma; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured | 2001 |